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Abstract
 
A role for immunoglobulin E and its high affinity receptor (Fc
 
e
 
RI) in the control of bacterial
pathogenicity and intestinal inflammation has been suggested, but relevant animal models are
lacking. Here we compare transgenic mice expressing a humanized Fc
 
e
 
RI (hFc
 
e
 
RI), with a
cell distribution similar to that in humans, to Fc
 
e
 
RI-deficient animals. In hFc
 
e
 
RI transgenic
mice, levels of colonic interleukin 4 were higher, the composition of fecal flora was greatly
modified, and bacterial translocation towards mesenteric lymph nodes was increased. In
hFc
 
e
 
RI transgenic mice, 2,4,6-tri-nitrobenzenesulfonic acid (TNBS)-induced colitis was also
more pronounced, whereas Fc
 
e
 
RI-deficient animals were protected from colitis, demonstrat-
ing that Fc
 
e
 
RI can affect the onset of intestinal inflammation.
Key words: immunoglobulin E receptor • bacterial translocation • intestinal permeability • 
inﬂammatory bowel disease • colitis
 
Introduction
 
IgE is known to induce inflammatory processes such as im-
mediate hypersensitivity reactions (allergy, asthma, anaphy-
laxis, etc.) through interaction with its high affinity recep-
tor, Fc
 
e
 
RI (1). Upon receptor aggregation with IgE and
multivalent antigen, cells release inflammatory mediators,
whether preformed, like histamine, or newly synthesized,
like leukotrienes. In mice, Fc
 
e
 
RI is expressed only on mast
cells and basophils, whereas in humans, it is additionally ex-
pressed on monocytes, Langerhans cells, eosinophils, and
platelets (1). To obtain the most suitable animal model for
the study of IgE-mediated diseases, we first generated trans-
genic (Tg)
 
1
 
 mice expressing the human Fc
 
e
 
RI
 
a
 
 (hFc
 
e
 
RI
 
a
 
)
chain under the control of its own promoter region (2).
Those hFc
 
e
 
RI
 
a 
 
Tg animals (bred in an Fc
 
e
 
RI-deficient
background), express a “humanized” receptor, with the
same cellular distribution as found in humans (3). This re-
ceptor is able to bind human or murine IgE and to restore
IgE-mediated anaphylaxis in Fc
 
e
 
RI-deficient (Fc
 
e
 
RI
 
a
 
2
 
/
 
2
 
)
mice (2, 4).
In chronic inflammatory bowel disease (IBD), intestinal
lesions are considered as the consequence of a dysfunction
of the mucosal immune system. Genetic and environmen-
tal factors have also been associated to the onset of the dis-
ease. Infectious agents such as
 
 Mycobacterium paratuberculosis
 
,
measles virus, and 
 
Listeria monocytogenes
 
 were once sus-
pected as causal agents (5). However, none of them were
formally confirmed as actually responsible for Crohn’s dis-
ease (CD), one of the two entities of IBD.
Most animal models, including 2,4,6-tri-nitrobenzene-
sulfonic acid (TNBS)-induced colitis in mice and rats, have
been described as “mediated” by type 1 cytokines. Indeed,
chronic intestinal lesions are associated with an increased
synthesis of proinflammatory and type 1 cytokines (5, 6).
However, more recent studies have demonstrated the im-
portance of type 2 cytokines for the induction of colitis. In
TCR-
 
a
 
–deficient animals (TCR-
 
a
 
2
 
/
 
2
 
) spontaneously de-
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veloping colitis (7), acute lesions are associated with an in-
creased IL-4 synthesis (8) and with local IgE production (9),
whereas chronic lesions are associated with type 1 cytokines
(8). Indeed TCR-
 
a
 
2
 
/
 
2 
 
3
 
 IL-4
 
2
 
/
 
2
 
 mice do not develop
colitis, whereas colitis in TCR-
 
a
 
2
 
/
 
2 
 
3
 
 IFN-
 
g
 
2
 
/
 
2 
 
animals is
similar to the pathology observed in TCR-
 
a
 
2
 
/
 
2 
 
3
 
 IFN-
 
g
 
1
 
/
 
1
 
 mice (10). Mucosal immune response is associated, in
TCR-
 
a
 
2
 
/
 
2 
 
and IL-2
 
2
 
/
 
2 
 
mice, to IgE synthesis (9, 11), and
is dependent on luminal bacteria (12, 13). Additionally, in
TNBS-induced colitis, disruption of the IL-4 gene or ad-
ministration of anti–IL-4 antibodies attenuates the severity
of the lesions, whereas disruption of the IFN-
 
g
 
 gene leads
to an increased pathology (14). The respective roles of type
1 and type 2 cytokines have been further delineated using
the same model. Indeed, a recently published study has
shown that Th1-like cytokine responses were inducing fa-
tal, acute, transmural, and focal types of lesions, whereas
Th2-like cytokine responses were playing a significant role
in the diffuse atrophic changes in crypts and the mucosal
layer that occur in the late stages of this disease (15).
Recently, we have shown that divergent mucosal cyto-
kine patterns evolved during the different stages of CD. A
type 2 pattern with prominent IL-4 response and local pro-
duction of IgE is associated with the early intestinal lesions
of patients with CD and followed by a type 1 response in
the chronic lesions of the same patients (16, 17). Further-
more, it has been shown that the enhancement of intestinal
permeability observed in patients with CD is associated
with an increase of activated B cells (CD45 RO
 
1
 
CD19
 
1
 
),
which have the capacity to synthesize IgE (18). Addition-
ally, we have demonstrated, in patients with type 2– and
IgE-mediated disease like atopy or asthma, the presence of
an airway-like inflammation of the gut, including high lev-
els of type 2 cytokines (19) and an increase of the intestinal
permeability (20). Taken together, these results suggest that
the common mucosal immune system could modify the in-
testinal permeability and therefrom bacterial translocation
through mechanisms involving IL-4/IgE and/or Fc
 
e
 
RI,
the high affinity IgE receptor.
Evidences for a role of the endogenous bacterial flora in
the bowel inflammation have also been accumulating (5).
In humans, the importance of bacterial flora was demon-
strated in a model of postsurgery relapse, which occurs at a
rate of 73% after 1 yr (21). If the anastomosis is isolated
from the fecal stream, no lesion occurs, whereas the relapse
is rapid after the infusion of intestinal luminal content (22).
We thus hypothesize that, in CD, lesions are due either to
compounds from the digestive flora or to virulent bacteria
invading the digestive tract in a patient with a defective im-
mune intestinal response. Indeed flora from stool samples,
obtained in patients with CD, contains higher concentra-
tions of anaerobic bacteria, among others 
 
Bacteroides vulgatus
 
and some coccobacilli (
 
Eubacterium
 
, 
 
Peptostreptococcus
 
, and
 
Coprococcus
 
 [23]). Likewise, a significant increase in the
number of luminal ileal and colic 
 
Bacteroides fragilis
 
 and
 
Escherichia coli 
 
was observed (24, 25), as well as an increase
of mucosal enterobacteria in biopsies (26). However, it has
not been so far formally demonstrated that such bacteria
 
were the causal agent of the disease. It is rather suspected
that the presence of these bacteria worsen the symptoms
initiated by alterations of the immune system. In most ani-
mal models of spontaneous colitis, the severity of the in-
flammatory lesions increases with the presence of the bac-
terial flora (6, 12, 27).
Using hFc
 
e
 
RI
 
a
 
 Tg and Fc
 
e
 
RI-deficient animals, we in-
vestigated if IgE receptor expression was affecting inflam-
matory parameters, bacterial flora and its translocation to-
wards mesenteric lymph nodes (MLNs) in naive animals.
Our results suggest that Fc
 
e
 
RI might be able to contribute
to the development of intestinal inflammation, possibly due
to increased levels of IL-4.
 
Materials and Methods
 
Animals.
 
Human Fc
 
e
 
RI
 
a
 
 Tg and Fc
 
e
 
RI
 
a
 
2
 
/
 
2
 
 mice that have
been described elsewhere (2–4) are in a Balb/c background. Un-
less specified, animals aged between 8 and 16 wk as well as corre-
sponding wild-type (WT) Balb/c were raised in a specific patho-
gen-free (SPF) facility, under a 12:12 h day–night illumination
cycle. Tap water was available ad libitum and animals were fed
with standard mice chow (D04; UAR).
 
Experimental Procedures.
 
Animals were killed by cervical dislo-
cation. MLNs were first aseptically removed before intestinal re-
section and placed immediately in cysteinated-strength Ringer’s
medium for microbiological analyses. Then, transparietal samples
of distal colon and ileum were resected and fixed in 4% paraform-
aldehyde (PFA) or snap frozen in liquid nitrogen, respectively, for
histologic examination and cytokine quantification. Samples of
feces were put in the same medium as above for microbiological
analyses.
 
Microbiological Analyses.
 
MLNs and feces were weighted. In-
oculations were performed within 4 h after animal sacrifice. Cul-
tures for both aerobic and anaerobic flora were performed on
Columbia blood agar either by direct inoculation or after an en-
richment in liquid Wilkins-West medium for detection of germs
present in small amounts. Anaerobic conditions were obtained in
hermetic jar using Anaerogen (Oxoid) reagent.
Results were expressed as log CFU per gram of feces for both
total counts and counts of identified bacteria. Detection limit for
mesenteric tissue was 
 
z
 
10 germs/g of tissue.
 
Reverse Transcription PCR.
 
Frozen colon samples were placed
in Trizol (Life Technologies), and total RNA was extracted ac-
cording to the manufacturer’s instructions (Bioprobe). Quantita-
tive reverse transcription (RT)-PCR was performed exactly as
described previously (16). pQB3 and pMus-3 were respectively
used as competitor for 
 
b
 
-actin and for IL-1
 
b
 
, IL-6, TNF-
 
a
 
, IL-
10, IFN-
 
g
 
, and IL-4 (a gift from Dr. D. Shire, Sanofi Elf Bio Re-
cherches, Labege, France). The size of the amplified fragments
and the sense and antisense primers are figured on Table I. Fc
 
e
 
RI
and IgE mRNA levels were determined by semiquantitative RT-
PCR. A fixed amount of cDNA, corresponding to the lowest
number of 
 
b
 
-actin cDNA molecules in the group of samples, was
used. Results were expressed as absorbance units (at 260 nm) per
molecule of 
 
b
 
-actin mRNA.
 
IgE Measurements.
 
Serum IgE concentrations were measured
as described previously (28). In brief, 96-well microtiter plates
(Maxisorb; Nunc) were coated overnight at 4
 
8
 
C with 2 
 
m
 
g/ml
purified anti–mouse IgE (clone R35-72; BD PharMingen) in
PBS buffer, pH 7.4. After washing, wells were saturated with
PBS–1% BSA. After washing, samples or anti-TNP IgE (clone 
27
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C48-2; BD PharMingen), used for the standard curve, were
added and incubated overnight at 4
 
8
 
C. After washing, biotiny-
lated anti-IgE antibody (2 
 
m
 
g/ml, clone R35-92; BD PharMin-
gen) was incubated for 1 h at room temperature. After washing,
plates were then incubated for 30 min at room temperature with
streptavidin-conjugated horseradish peroxidase (1:10,000; Jackson
ImmunoResearch Laboratories) and reactions were revealed by
addition of ortho-phenylenediamine (OPD). Absorbance was
read at 492 nm.
 
Pathological Analyses.
 
4-
 
m
 
m paraffin sections were stained
with May-Grünwald/Giemsa and examined for morphology and
presence of inflammatory infiltrates. Microscopic inflammatory
score was measured according to Ameho et al. (29).
 
Intestinal Permeability.
 
Intestinal permeability was measured
according to Meddings and Gibbons (30). Mice were denied ac-
cess to water for 3 h. Then, each mouse was given, by gavage, 8
mg mannitol, 12 mg lactulose, and 6 mg sucralose in 200 
 
m
 
l
drinking water. Groups of five mice were placed into stainless
steel metabolic cages in order to separate feces from urine. 10 
 
m
 
l
of a 10% sodium azide solution were added to each collecting
tube to prevent bacterial degradation of urinary sugars. Urine was
collected for a total of 24 h and frozen until measurement of its
sugar composition. After thawing, d(
 
1
 
)furanose was added as in-
ternal standard, and samples were deionized using a mixture of
Amberlite IR-120 plus and IRA-400c resin. After centrifugation,
samples were evaporated under nitrogen and derivatized with bis-
(trimethylsilyl)trifluoroacetamide (BSTFA) plus trimethylchlo-
rosilane (TMCS) (1%) after reaction with NH
 
2
 
OH.HCl in pyri-
dine. Sucralose, lactulose, and mannitol were determined by gas
chromatography-flame ionization detector (GC-FID) after ex-
traction in n-heptane using a 100% dimethylpolysiloxane column
(CP-Sil 5 CB Low Bleed/MS; Variant; 25 m 
 
3
 
 0.25 mm, diam-
eter 0.2 mm) with a multirise temperature program. All samples
were diluted so that concentrations fell within the range of the
standards.
 
TNBS-induced Colitis.
 
For induction of colitis, mice were
anesthetized for 90–120 min with Xylazine (50 mg/kg; Rom-
pun
 
®
 
 2%; Bayer Pharma) and Ketamine (50 mg/kg; Imalgene
 
®
 
1000; Rhône Mérieux). TNBS (150 mg/kg; Fluka) was adminis-
tered intrarectally in 40 
 
m
 
l 50% ethanol via a 3.5 F catheter (Ref
EO 3416-1; Biotrol) inserted to a length of 4 cm (31). Control
mice received 40 
 
m
 
l 50% ethanol saline or saline alone. Animals
were killed 48 h later. Macroscopic lesions were assessed accord-
ing to the score established by Wallace et al
 
. (32).
Statistical Analysis. Comparisons between number of bacteria
in the feces, number of bacteria in the MLN, and cytokine
cDNA levels in the Tg and WT mice were analyzed by the
Kruskall-Wallis test. Differences were statistically significant if the
P value was ,0.05.
Results
To study the role of FceRI on intestinal inflammation,
three different strains of mice expressing FceRI at different
levels and with a different cell distribution were compared:
WT Balb/c mice expressing FceRI only on mast cells and
basophils, hFceRIa Tg mice expressing a functional hu-
manized receptor on mast cells, basophils, monocytes, eo-
sinophils, and epidermal Langerhans cells, and FceRIa2/2
animals in which receptor expression is absent. To correlate
receptor expression levels with the observed phenotype,
steady-state levels of FceRIa mRNA were determined in
colonic samples using semiquantitative RT-PCR. Primers
were chosen in regions displaying 100% homology be-
tween human and mouse, so that amplification efficiency
was identical in WT and hFceRIa Tg mice. Fig. 1 (top)
shows that receptor expression is z8.5-fold higher in Tg
than in WT animals. As expected, no mRNA amplification
was detected for FceRIa2/2 animals.
Igs. To rule out that differences in IgE levels between
the groups of animals would be superimposed to differen-
tial expression of the receptor, presence of the productive
transcript for IgE was assessed in the colon by semiquantita-
tive RT-PCR. No differences were observed in the sam-
ples from the three groups of mice (Fig. 1, bottom), show-
ing that IgE production by intestinal plasmocytes was
comparable. Likewise, total IgE concentrations in the se-
Table I. Primer Sequences and Amplicon Size for Amplification of Cytokine cDNA, FceRIa, IgE Productive Transcript, b-actin cDNA, and 
Corresponding Competitors
Amplicon length
Sense primer Antisense primer
Cytokine
cDNA Competitor
bp bp
IL-1b 59-TTG ACG GAC CCC AAA AGA TG-39 59-AGA AGG TGC TCA TGT CCT CAT-39 205 435
IL-6 59-GTT CTC TGG GAA ATC GTG GA-39 59-TGT ACT CCA GGT AGC TAT GG-39 209 435
TNF-a 59-TCT CAT CAG TTC TAT GGC CC-39 59-GGG AGT AGA CAA GGT ACA AC-39 212 435
IFN-g 59-GCT CTG AGA CAA TGA ACG CT-39 59-AAA GAG ATA ATC TGG CTC TGC-39 229 436
IL-4 59-TCG GCA TTT TGA ACG AGG TC-39 59-GAA AAG CCC GAA AGA GTC TC-39 216 435
IL-10 59-ATG CAG GAC TTT AAG GGT TAC TTG-39 59-AGA CAC CTT GGT CTT GGA GCT TA-39 253 442
b-actin 59-GGG TCA GAA GGA TTC CTA TG-39 59-GGT CTC AAA CAT GAT CTG GG-39 238 376
IgE (pe)5 9-TGG ACT ACT GGG GTC AAG G-39 59-AGC GAT GAA TGG AGT AGC-39 365 2
FceRIa 59-CTC CTT CAG RCM TCT GCT GA-39 59-TGT CCA CAG CAA ACA GAA TC-39 318 228 IgE Receptor in Bacterial Translocation and Intestinal Inflammation
rum were also measured by ELISA. Human FceRIa Tg,
Balb/c, and FceRIa2/2 mice were presenting comparable
levels of IgE (2.46 6 1.64, 2.40 6 0.99, and 1.80 6 0.93
mg/ml, respectively).
Human FceRIa Tg and FceRIa2/2 Mice Do Not Develop
Spontaneous Colitis and Display Normal Intestinal Morphol-
ogy. Macroscopic and microscopic aspects of the digestive
tract from hFcRIa Tg, FceRIa2/2, and corresponding
Balb/c mice housed in an SPF facility were then examined.
No differences could be observed between the animals in
the three groups in either colon or ileum. No sign of spon-
taneous colitis or inflammation was detectable in any of the
animals examined (null score for both macroscopic and mi-
croscopic inflammation, absence of eosinophilia, and of
mast cell degranulation; Fig. 2).
Human FceRIa Tg Mice Express Increased Levels of Colonic
IL-4. Alterations in cytokine patterns have been evi-
denced in spontaneously occurring as well as in experimen-
tally induced colitis. To determine if levels of FceRI
expression would affect intestinal cytokine production,
mRNA for proinflammatory (IL-1b, TNF-a) and immu-
noregulatory (IL-10, IFN-g, and IL-4) cytokines were ana-
lyzed in colon and small intestine samples of hFceRIa Tg,
WT, and FcRIa2/2 mice, using quantitative RT-PCR.
No differences in cytokine mRNA were observed in small
intestine. However, in the colon from hFceRIa Tg mice,
IL-4 and IL-10 levels were respectively increased four- and
fivefold compared with WT animals, whereas, in FcRIa2/2
animals, IFN-g was increased fourfold when compared
with WT (Fig. 3). Cytokine levels in the colon and IL-4 in
particular were thus differing from one group to the other.
Human FceRIa Tg Mice Display Increased Intestinal Perme-
ability. IL-4 has been shown to affect transcellular and
paracellular antigen transport across intestinal epithelium in
vitro (33). Small intestine and colon permeability were thus
measured in vivo, in the three groups of animals, by gavage
with lactulose, mannitol and sucralose, followed by mea-
surements of urinary sugar concentrations. Urinary lactu-
lose/mannitol ratio (a marker of small intestinal permeabil-
ity) was increased 5.4-fold in hFceRIa Tg animals
compared with both WT and FceRIa2/2 mice, and the co-
lon permeability evaluated by lactulose/sucralose ratio was
comparable (Fig. 4). This suggests that differences in the in-
testinal permeability between the mouse strains are mainly
restricted to the small intestine and do not affect colon.
Figure 1. Expression of FceRIa transcripts (top), b-actin (middle), and
IgE productive transcripts (pe; bottom) in hFceRIa Tg, WT, and
FceRIa2/2 mice. Ethidium bromide–stained agarose gels were loaded
with amplified PCR products from individual mice.
Figure 2. Histology of colon mucosa from hFceRIa Tg, WT, and FceRIa2/2 mice after May-Grünwald/Giemsa staining of paraffin-embedded
4-mm sections. Bars, 0.2 mm.29 Dombrowicz et al.
To detect potential alterations in tight junctions, the
main element controlling paracellular transport across the
epithelium, immunohistochemistry was performed to de-
tect occludin and ZO-1, two major proteins of the tight
junction complex (34). Specific staining for occludin was
detected on colon and small intestine preparations from the
three groups of animals. No differences were observed be-
tween the groups. No ZO-1 staining was observed on any
intestine sections, whereas Z0-1 mRNA was detected by
RT-PCR on the same samples and kidneys of the same an-
imals showed a strong positive immunostaining (data not
shown). Taken together, these data suggest that elevated
transcellular rather than paracellular permeability is ac-
counting for the increased permeability in the small intes-
tine from hFceRIa Tg mice.
Human FceRIa Tg Mice Have an Altered Bacterial Flora and
Display Increased Translocation towards MLNs. As an in-
creased intestinal permeability might facilitate the transloca-
tion of bacteria to the gut lumen and would thus give way
to potential infection and inflammation, bacterial flora in
the lumen and in MLNs from hFceRIa Tg, FceRIa2/2,
and WT mice was compared (Fig. 5). Total numbers of aer-
obic and anaerobic germs were similar in the feces from the
three groups of animals. Lactobacillus appeared as the most
prominent genus. Interestingly, Bacteroides in hFceRIa Tg
Figure 3. Cytokine mRNA
levels in the colon of hFceRIa
Tg, WT, and FceRIa2/2 mice.
IFN-g, IL1-b, TNF-a, IL-10,
and IL-4 were quantified by
competitive RT-PCR from co-
lon mRNA (n 5 13 for FceRIa
Tg mice, n 5 13 for WT mice,
and n 5 6 for FceRIa2/2 mice).
Results are expressed as number
of cytokine mRNA molecules
per 104 molecules of b-actin. In-
dividual values, mean, and SD
are represented.
Figure 4. Intestinal permeability in hFceRIa Tg, WT, and FceRIa2/2
mice. Lactulose/mannitol and lactulose/sucralose ratio in the urine col-
lected over a 24-h period after gavage. Bars represent pools from five
mice.30 IgE Receptor in Bacterial Translocation and Intestinal Inflammation
animals were z5,000- and 50-fold more abundant than in
WT and FceRIa2/2 animals, respectively. Bifidobacterium
was z40-fold more abundant in FceRIa2/2 than in the
two other groups (Fig. 5 a). No significant differences be-
tween the three groups were found for other germs. These
data show that the status of FceRI expression influences the
relative composition of the fecal flora.
Compared with fecal flora, the number of germs present
in the MLNs was lower by six to seven orders of magni-
tude in the three types of animals (Fig. 5 b). Overall, trans-
location was 50- and 30-fold higher in hFceRIa Tg mice
than in WT animals and FceRIa2/2, respectively. Lactoba-
cillus species were overwhelmingly dominant. Lactobacillus
brevis, Lactobacillus lactis lactis, and Lactobacillus plantarum
were the identified species present. Occasionally, E. coli or
Enterococcus species were isolated. As expected for a strictly
anaerobic strain, no Bacteroides were translocating to the
MLNs. Thus, additional expression of FceRI in hFceRIa
Tg mice promotes selective translocation of mainly non-
pathological aero-anaerobic bacteria from the lumen to the
MLNs, in the absence of intestinal inflammation.
As some colitis-prone strains, such as IL-2–deficient
mice, do not develop pathology when housed in germ-free
conditions (12), we investigated if mice maintained in a
conventional facility, rather than in an SPF facility, would
develop colitis or inflammation. Animals were killed 1 mo
after their transfer from the SPF facility. No colitis or mor-
phological alterations were detected in any of the three
strains. Along the same lines, data obtained for the compo-
sition of the flora and its translocation towards MLNs were
not statistically different from these observed for SPF-raised
mice (not shown). Environmental conditions do not appear
to greatly affect the bacterial flora in any of the three strains
of mice.
TNBS-induced Colitis Is Increased in hFceRIa Tg and Ab-
sent in FceRIa2/2 Mice. As it has been recently demon-
strated that IL-4 was one of the key factors for the onset of
TNBS-induced colitis in Balb/c mice and that some bacte-
rial strains, such as Bacteroides, were aggravating intestinal
inflammation, the effects of TNBS in the three groups of
mice were investigated. 48 h after TNBS administration,
four out of seven hFceRIa Tg mice and one out of seven
WT mice had died. Colitis in the surviving Tg animals was
very severe, with edema mainly affecting the submucosa
and necrosis localized in the mucosal area (Fig. 6, left, and
Table II). WT animals displayed milder colitis, with mod-
erate submucosal infiltration and some epithelial ulcerations
(Fig. 6, middle, and Table II). Most strikingly, FceRIa2/2
were totally lacking signs of colitis, and colon from these
animals were virtually identical to those from ethanol-
treated animals (Fig. 6, right, and Table II). FceRI expres-
sion thus seems required for the development of TNBS-
induced colitis.
Discussion
In this study, we investigated the effects of FceRI ex-
pression on intestinal inflammation using hFceRIa Tg
mice, which express the high affinity receptor with a cell
distribution similar to that found in humans, WT, and
FceRI-deficient mice. Indeed, in contrast to humans, mice
are lacking high affinity IgE receptor expression on eosino-
Figure 5. Luminal (a) and
MLN (b) flora from hFceRIa
Tg, WT, and FceRIa2/2 mice.
Germ number in feces from the
three strains of mice were ana-
lyzed after culture of both aero-
bic and anaerobic flora. Results
are expressed as mean numbers
of bacteria per gram of feces or
tissue 6 SD (n 5 7 for hFceRIa
Tg, n 5 8 for WT, and n 5 15
for FceRIa2/2 mice; *P , 0.05).
Error bars (a) are falling within
the top line of each histogram.31 Dombrowicz et al.
phils, macrophages, and platelets, making them inadequate
to fully evaluate IgE-dependent inflammation.
No sign of inflammation, eosinophilia, or mast cell de-
granulation were detected in any of the three strains of
mice; however, increased levels of IL-4 were detected in
the colon from hFceRIa Tg animals. This cytokine has
been shown to increase epithelial permeability in vitro (33).
Furthermore, an increase in intestinal permeability was ob-
served in patients with type 2–associated pathologies and
IgE such as atopy and asthma (20). In vivo measurements of
intestinal permeability revealed an increased lactulose/man-
nitol ratio but no changes in lactulose/sucralose ratio in
hFceRIa Tg mice. This indicates that, in these animals,
small intestine permeability rather than colonic permeabil-
ity was affected. Increased expression of IL-4 in hFceRI-
aTg mice associated with an increased permeability of the
small intestine is thus fully in agreement with these previ-
ous experimental and clinical observations.
A modification of the intestinal flora and an increased
bacterial translocation in the absence of spontaneous colitis
were observed only in hFceRIa Tg mice. The three
groups of mice were on the same Balb/c background and
raised in the same room, therefore excluding any bias due
to genetic factors in the results. Furthermore, no significant
difference in the fecal flora was detected, whether animals
were raised in a SPF or in a regular animal facility. This
Figure 6. Macroscopic (a) and microscopic (b) evaluations of colons from hFceRIaTg, WT, and FceRIa2/2 mice 48 h after intrarectal TNBS admin-
istration. Colons were open along the longitudinal axis for photography. (a) Colons of TNBS-treated hFceRIa Tg mice display intense inflammation
with edema and necrosis compared with the mild inflammation observed in the colon of WT animals and to the absence of inflammation in colons from
TNBS-treated FceRIa2/2 mice. One representative colon for each strain of mice is shown. Distal colon is on the left side. (b) 4-mm paraffin-embedded
sections were stained with May-Grünwald/Giemsa. Bar, 0.2 mm.
Table II. Macroscopic and Histological Scores of Colons from 
hFceRIa Tg, WT, and FceRIa2/2 Mice 48 h after Intrarectal 
TNBS Administration
hFceRIa Tg WT FceRIa2/2
Death rate 4/7 1/6 0/6
Macroscopical score 4.6 6 2 1.6 6 2.3 0.33 6 0.8
Histological score 3.33 6 2.5 1.4 6 2.6 1.16 6 1.19
Scores were determined according to Ameho et al. (reference 28) and
Wallace et al. (reference 31). Results are expressed as mean 6 SD.32 IgE Receptor in Bacterial Translocation and Intestinal Inflammation
suggests that the composition of the flora was not modified
according to the external environment. Similarly, no quan-
titative differences in the fecal flora between the three
groups of animals were detected. In contrast, major qualita-
tive differences were observed. Indeed, Bacteroides was
5,000- and 50-fold more abundant in hFceRIaTg than in
WT and FceRI-deficient animals, respectively. These
strictly anaerobic bacteria have been associated in the colitis
occurring in a rat model with a modified immune system
(HLA-B27/b2 microglobulin Tg animals). Indeed, the
normal endogenous flora (containing Bacteroides) is suffi-
cient to trigger colitis in these animals, whereas non-Tg an-
imals harboring the same flora do not develop colitis. Coli-
tis in Tg rats can only be prevented by keeping the animals
in germ-free conditions (35). Furthermore, increased num-
ber of B. vulgatus are found in feces from patients with CD
(23). Likewise, a significant increase in the number of lu-
minal ileal and colic B. fragilis has been observed (24). Fi-
nally, Bacteroides was also associated to an extra-intestinal
inflammatory pathology. Indeed, a comparative study be-
tween healthy Estonian (country with low atopy preva-
lence) and Swedish (country with high atopy prevalence)
1-yr-old children, has shown that the former had higher
number of Lactobacilli and Eubacteria, whereas the later dis-
played higher number of Bacteroides and Clostridia (36). In-
creased population of Bifidobacterium, which are 40-fold
more abundant in FceRI-deficient animals, have been in-
volved in the development of gut-associated lymphoid tis-
sue in neonates and in particular in the regulation of type 2
responses in mice (37). Levels of FceRI expression and dif-
ferences in receptor cellular distribution thus affect the
composition of fecal flora.
As expected after the permeability measurements, bacte-
rial translocation from the intestinal lumen towards MLNs
was also affected by FceRI expression. The increased spon-
taneous translocation observed in hFceRIa Tg animals was
mainly affecting Lactobacillus. There were no Bacteroides
found in MLNs from any strain of animal. Indeed, it has
been reported that aerobes such as Lactobacillus are very effi-
ciently translocated, whereas anaerobic germs, such as
Bacteroides, poorly translocate (38). Would some anaerobic
bacteria cross the intestinal wall and reach the peritoneal
cavity, they would not withstand the aerobic environment
and thus do not survive lest proliferate.
Although mechanisms of bacterial translocation are still
unclear, it is considered that bacteria are either crossing the
intestinal wall by a transcellular way or taking a paracellular
route (38). In this later case, a disruption or some loosening
of the tight junctions maintaining the integrity of the epi-
thelial barrier would have to take place. However, no
modification of occludin expression was detected by im-
munohistochemistry. As tight junctions do not seem to be
affected, it is likely that an increased transcellular passage of
bacteria is responsible for the increased bacterial transloca-
tion. There is no report so far on Lactobacillus-specific trans-
cytosis mechanisms. It has been reported that Campylo-
bacter jejuni were translocating across Caco-2 cells using a
paracellular way (39). Likewise, E. coli isolated from pa-
tients with necrotizing enterocolitis were transcytosed in
vitro in the absence of ultrastructural changes (40).
In the present model of acute TNBS-induced colitis
(31), strikingly different effects were observed on the three
strains of mice. FceRI-deficient mice were completely pro-
tected from colitis, suggesting that FceRI expressed on
mast cells (and basophils) was involved in the pathology
onset. By contrast, colitis in hFceRIaTg mice was exacer-
bated, even leading to a high death rate. Higher IL-4 levels
in these colitis-sensitive animals are in agreement with the
inhibition of chronic (10 d) TNBS-induced colitis in IL-4–
deficient animals (14) and with the absence of colitis in
TCR-a2/2 3 IL-42/2 animals (10). Furthermore, the in-
creased number of Bacteroides found in hFceRIa Tg might
also have increased the severity of colitis, as demonstrated
previously on TNBS-induced colitis in rat (41, 42). Finally,
additional FceRI expression on eosinophils and macro-
phages compared with WT animals might also contribute to
the increased pathology by affecting the intestinal barrier.
hFceRIaTg mice might thus be considered in a state of
“pre-IBD” with increased number of luminal Bacteroides,
increased Lactobacillus translocation to the MLNs, increased
small intestinal permeability, higher colonic levels of IL-4,
but no macroscopic or microscopic symptom of inflamma-
tion. Along these lines, increase of intestinal permeability
(measured by lactulose/mannitol ratio) in the absence of a
clinical sign of inflammation has been considered as a
predictive marker of relapse in patients with remitting CD
(43, 44).
If bacterial flora has been shown to influence the devel-
opment of immune responses (45), we have reported here
that alterations of the immune system were also able to af-
fect bacterial flora and its translocation. Besides the in-
volvement of FceRI in susceptibility to intestinal inflam-
mation, we have recently obtained evidences that IgE was
also increasing susceptibility to colitis (Nutten, S., manu-
script in preparation). Thus, pharmacological targeting of
IgE or its high affinity receptor, with reagents such as
nonanaphylactogenic anti-IgE antibodies, would therefore
be potentially useful for treatment of IBD. In this context,
colitis-prone hFceRIa Tg mice represent a valuable model
to assess the potency of compounds, which would prevent
the development of clinically detectable inflammation.
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